http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-708247-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e1503069238009851ded999ea9ad833 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20 |
| filingDate | 2011-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_451e9110318575b2fcb4865edfb5fc27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3658c5371baa1e4f42054311b63671f |
| publicationDate | 2017-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-708247-A |
| titleOfInvention | Hyaluronic acid based formulations |
| abstract | Discloses a soft tissue filler composition comprising: (1) a crosslinked hyaluronic acid (HA) component comprising a crosslinked mixture of (i) a first, low molecular weight HA material having a weight average molecular weight of between 0.20 about MDa and about 0.99 MDa and (ii) a second high molecular weight HA material having a weight average molecular weight of between about 1.0 MDa and about 4.0 MDa; wherein the weight average molecular weight of the second, high molecular weight HA material is at least twice that of the first, low molecular weight HA material; wherein the HA materials are hyaluronic acid or one or more salts thereof; wherein the crosslinked HA component has a HA concentration of between about 15.0 mg/g and about 20.0 mg/g; and wherein the crosslinking is achieved by use of a crosslinking agent; and (2) an uncrosslinked HA component which is HA or a salt thereof, and which has a weight average molecular weight of at least about 1.0 MDa and is present in the composition in an amount of less than about 5.0% w/w. |
| priorityDate | 2010-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392 |
Total number of triples: 23.